News

2021/10/22

【Bio X Cell】Antibodies Targeting CD Markers


Bio X Cell抗體一直以來都是科學家們選擇in vivo等級抗體的首選。20多年來,有超過15,000篇的出版刊物引用Bio X Cell產品,我們深知這一責任的重要性,將繼續致力於生產高品質的單株抗體,協助推動相關研究領域的發展。
 

經典CD Markers產品:
α-mouse CD309 (VEGFR-2) (BP0060) α-mouse CD134 (OX40 ) (BP0031)
 
InVivoMab vs. InVivoPlus
Purity level InVivoMab
>95%
InVivoPlus
>95%
protein aggregates validated at ≤5%  
azide and carrier protein free
endotoxin concentration < 2EU/mg < 1EU/mg
validated by immunoblot, FC, or ELISA  
tested for murine pathogens  
available in bulk quantities
 **更多抗體資訊請洽捷昇業務

 
Antigen Reactivity Application Clone InVivoMab
Catalog
InVivoPlu
Catalog
4-1BB (CD137) mouse in vivo and in vitro 4-1BB stimulation 3H3 BE0239 BP0239
4-1BB (CD137) mouse in vitro 4-1BB blockade, FC 17B5 BE0296  
4-1BBL (CD137L) mouse in vivo 4-1BBL blockade TKS-1 BE0110  
B7-1 (CD80) mouse in vivo B7-1 blockade, Affinity chromatography 1G10 BE0134  
BTLA (CD272) mouse in vivo BTLA stimulation, in vivo BTLA blockade 6A6 BE0132  
BTLA (CD272) mouse in vivo BTLA+ B cell and CD4 T cell depletion, FC 6F7 BE0304  
CD19 mouse in vivo B cell depletion, in vivo CD19 neutralization, in vitro B cell negative selection, FC 1D3 BE0150  
CD19 human FC, Functional assays, IF, Chimeric antigen receptor construction 4G7 BE0281  
CD20 human/monkey in vivo B cell depletion in hCD20 Tg mice, IHC-F, IP, FC 2H7 BE0276  
CD20 mouse FC, WB AISB12 BE0302  
CD28 mouse in vitro T cell stimulation/activation, in vivo CD28 blockade 37.51 BE0015-1  
CD28 human/monkey in vitro T cell stimulation/activation, FC, IHC-F CD28.2 BE0291  
CD40 mouse in vivo CD40 activation, in vitro B cell stimulation/activation FGK4.5/FGK45 BE0016-2  
CD40L (CD154) mouse in vivo and in vitro blocking of CD40/CD40L signaling MR-1 BE0017-1 BP0016-2
CD40L (CD154) human/monkey in vitro and in vivo blocking of CD40/CD40L signaling, IP, FC 5C8 BE0292 BP0017-1
CD44 mouse/human in vivo CD44 neutralization IM7 BE0039  
CD44 human in vitro CD44 blockade, WB, IF Hermes-1 BE0262  
CD47 human/mouse/rat in vivo CD47 blockade, in vitro CD47 blockade, IF MIAP410 BE0283  
CD47 (IAP) mouse in vivo CD47 blockade, IF MIAP301 BE0270  
CD80 (B7-1) mouse in vivo CD80 blockade, FC 16-10A1 BE0024  
CD86 (B7-2) mouse in vivo CD86 blockade, FC GL-1 BE0025  
CD96 mouse in vivo and in vitro CD96 blocking, FC 3.3 BE0337  
CD103 mouse in vivo CD103 neutralization, IF, FC M290 BE0026  
CD172a (SIRPα) mouse in vivo and in vitro SIRPα blocking, WB, IP, FC P84 BE0322  
CD209b (SIGN-R1) mouse in vivo SIGN-R1 blockade, IHC-F, WB, FC 22D1 BE0220  
CD276 (B7-H3) mouse in vivo B7-H3 blockade, FC MJ18 BE0124  
CD314 (NKG2D) mouse in vivo and in vitro NKG2D blockade, FC CX5 BE0334  
c-Kit (CD117) mouse in vivo mast cell depletion, in vivo c-Kit+ cell depletion, in vitro c-Kit neutralization, IP, FC ACK2 BE0293  
c-myc human WB, ELISA, FC 9E10 BE0238  
CSF1R (CD115) mouse in vivo macrophage depletion, in vitro CSF-R1 neutralization, in vivo monocyte depletion, FC AFS98 BE0213  
CSF1R (CD115) human in vitro CSF1R neutralization, IHC-P, Functional assays, FC 2-4A5-4 BE0347